Premium
Overcoming TKI resistance in a patient with chronic myeloid leukemia using combination BCR‐ABL inhibition with asciminib and bosutinib
Author(s) -
Hall Kevin H.,
Brooks Angelique,
Waller Edmund K.
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26231
Subject(s) - bosutinib , dasatinib , medicine , nilotinib , imatinib , leukocytosis , myeloid leukemia , imatinib mesylate , thrombocytosis , gastroenterology , cancer research , immunology , platelet
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom